Albireo Pharma (NASDAQ:ALBO) reported its Q2 earnings results on Monday, August 15, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

Albireo Pharma missed estimated earnings by 23.64%, reporting an EPS of $-2.04 versus an estimate of $-1.65.

Revenue was up $5.78 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.34 which was followed by a 18.37% drop in the share price the next day.

Here's a look at Albireo Pharma's past performance:

To track all earnings releases for Albireo Pharma visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.